ALOPESİ AREATA’DA TNF-α PROMOTÖR POLİMORFİZMİNİN ANALİZİ
Yıl: 2017 Cilt: 18 Sayı: 1 Sayfa Aralığı: 7 - 12 Metin Dili: Türkçe İndeks Tarihi: 04-12-2018
ALOPESİ AREATA’DA TNF-α PROMOTÖR POLİMORFİZMİNİN ANALİZİ
Öz: AMAÇ: Alopesi Areata patogenezinde, değiş-miş T hücre aracılı bağışıklığın rol aldığını göste-ren çok sayıda çalışma bulunmaktadır. Sitokin-lerin ve kemokinlerin Alopesi Areata’nın immun sürecinde önemli rol oynamasından dolayı, Alo-pesi Areata’ya yatkınlık ile TNF-α-308G/A poli-morfizmi arasındaki olası bağlantının Türk po-pulasyonunda araştırılması amacıyla bu çalışma gerçekleştirildi.GEREÇ VE YÖNTEM: Sunulan vaka kontrol ça-lışmasına 107 Alopesi Areata hastası ve 113 sağlıklı kontrol bireyi dahil edildi. TNF-α-308G/A polimorfizminin genotiplendirmesi Polimeraz Zincir Reaksiyonu (PZR) ve Restriksiyon Enzim Analizi (REA) yöntemleri ile gerçekleştirildi.BULGULAR: Hasta ve kontrol gruplarında TNF-α-308 G/A genotiplerinin ve allel frekans-larının dağılımı arasında anlamlı bir bağlantı bulunamadı (p=0.673 ve p=0.177, sırasıyla). Benzer şekilde, TNF-α-308 G/A polimorfizmi ile Alopesi Areata’nın klinik bulguları arasında fark tespit edilemedi.SONUÇ: Bu çalışma, TNF-α-308 G/A polimor-fizminin Türk populasyonunda Alopesi Areata gelişiminde önemli bir rol oynamadığını gös-termektedir.
Anahtar Kelime: Konular:
ANALYSIS OF TNF-α PROMOTER POLYMORPHISM IN ALOPECIA AREATA
Öz: OBJECTIVE: Most evidence supports the role of altered T cell-mediated immunity in the pat-hogenesis of alopecia areata. As though cyto-kines and chemokines play an important role in the immune process of Alopesi Areata, the purpose of the present study was to investigate possible associations between TNF-α-308G/A polymorphism and Alopesi Areata susceptibi-lity, and disease progression in Turkish popula-tion. MATERIALS AND METHODS: This case-control study included 107 unrelated patients with Alo-pesi Areata and 113 unrelated healthy controls. The genotyping of TNF-α-308G/A polymorp-hism was performed using polymerase chain reaction (PCR) combined with restriction enzy-me analysis (REA). RESULTS: No statistically significant associati-ons was found between Alopesi Areata patients and healthy subjects fort the TNF-α-308G/A ge-notypic and allelic distribution (p=0.673 and p=0.177, respectively). Similarly, no significant differences was observed between TNF-α-308G/A polymorphism and clinical manifestati-ons of Alopesi Areata. CONCLUSION: This study indicates that TNF-α-308G/A polymorphism do not play a significant role in Alopesi Areata susceptibility in Turkish Alopesi Areata patients.
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 34. Akman A, Sallakcı N, Coskun M, et al. TNF- TNF-a gene 1031 T/C polymorphism in Turkish patients with Behçet’s disease. Br J Dermatol 2006;155:350–6.
- 33. Ates O, Kurt S, Altinisik J, Bozkurt N, Karaer H. Genetic variations in Tumor Necrosis Factor alpha, Interleukin 10 genes and migraine susceptibility. Pain Medicine 2011:12:1464-1469
- 32. Ates O, Dalyan L, Hatemi G, Hamuryudan V, Topal-Sarıkaya A. Analyses of functional IL10 and TNF- α genotypes in Behçet’s Syndrome. Molecular Biology Reports 2010;37:3637-3641
- 31. Ates O, Musellim B, Ongen G, Topal-Sarıkaya A. Analyses of TNF polymorphisms in Turkish systemic sclerosis patients with interstitial lung involvement. Biochemical Genetics 2008;46:696-701
- 30. Ates O, Gulen H, Hamuryudan V, Topal-Sarıkaya A. Tumor Necrosis Factor-Alpha and Interleukin 10 Gene Promoter Polymorphismsm in Turkish Rheumatoid Arthritis Patients. Clinical Rheumatology 2008;27:1243-1248
- 29. Ates O, Musellim B, Ongen G, Topal-Sarıkaya A. Interleukin-10 and Tumor Necrosis Factor-α Gene Polymorphisms in Tuberculosis. Journal of Clinical Immunology 2008;28:232-236.
- 28. Teraki Y, Imanishi K, Shiohara T. Cytokines in alopecia areata: contrasting cytokine profiles in localized form and extensive form (alopecia universalis). Acta Derm Venereol. 1996;76:421–3.
- 27. Barahmani N, Lopez A, Babu D, et al. Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy. Clin Exp Dermatol. 2010;35:409–16
- 26. Nicholson LB, Kuchroo VK. Manipulation of the Th1/ Th2 balance in autoimmune disease. Curr Opin Immunol 1996;8:837–842
- 25. Olsen EA, Hordinsky MK, Price VH et al. Alopecia areata investigational assessment guidelines-part II. National alopecia areata foundation. J Am Acad Dermatol 2004;51:440–447
- 24. Kalkan G, Ateş O, Karakuş N, Sezer S. Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of alopecia areata. Arch Dermatol Res. 2013;305(10):909-15
- 23. Nie G, Qi JH, Huang CW, Yang T, Shi N, Chen YJ. Meta-analysis of the TNF-α-308G/A polymorphism and vitiligo risk. Genet Mol Res. 2015;14(4):17296-304.
- 22. Tauber M, Buche S, Reygagne P et al. Groupe de Recherche sur Psoriasis de Société Française de, Dermatologie; Club Rhumatismes et Inflammation (CRI); Groupe d’études thérapeutiques des affections inflammatoires du tube digestif (GETAID). Alopecia areata occurring during anti-TNF therapy: a national multicenter prospective study. J Am Acad Dermatol. 2014;70(6):1146-9.
- 21. Redler S, Albert F, Brockschmidt FF,et al. Investigation of selected cytokine genes suggests that IL2RA and the TNF/LTA locus are risk factors for severe alopecia areata. Br J Dermatol. 2012;167(6):1360-5.
- 20. Galbraith GM, Pandey JP. Tumor necrosis factor alpha (TNF-alpha) gene polymorphism in alopecia areata. Hum Genet. 1995;96(4):433-6.
- 19. Kasumagic-Halilovic E, Prohic A, Cavaljuga S. Tumor necrosis factor-alpha in patients with alopecia areata. Indian J Dermatol. 2011;56(5):494-6.
- 18. Bilgic O, Sivrikaya A, Unlu A, Altinyazar HC. Serum cytokine and chemokine profiles in patients with alopecia areata. J Dermatolog Treat. 2016;27(3):260-3.
- 17. Atwa MA, Youssef N, Bayoumy NM. T-helper 17 cytokines (interleukins 17, 21, 22, and 6, and tumor necrosis factor-α) in patients with alopecia areata: association with clinical type and severity. Int J Dermatol. 2015 Jul 31. doi: 10.1111/ijd.12808. [Epub ahead of print]
- 16. Rossi A, Cantisani C, Carlesimo M, et al. Serum concentrations of IL-2, IL-6, IL-12 and TNF-α in patients with alopecia areata. Int J Immunopathol Pharmacol. 2012;25(3):781-8.
- 15. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997;94:3195–9.
- 14. Kroeger KM, Carville KS, Abraham LJ. The -308 tumour necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 1997;34:391–9.
- 13. Bouma G, Crusius JB, Oudkerk Pool M, et al. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles: relevance for inflammatory bowel disease. Scand J Immunol 1996;43:456–463
- 12. Kroeger KM, Steer JH, Joyce DA, Abraham LJ. Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism. Cytokine. 2000;12(2):110-9.
- 11. Beutler B, Cerami A. The biology of cachectin/TNF-A primary mediator of the host response. Annu Rev Immunol 1989;7:625
- 10. Tembhre MK, Sharma VK. T-helper and regulatory T-cell cytokinesin the peripheral blood of patients with active alopecia areata. Br J Dermatol. 2013;169:543–8.
- 9. Islam N, Leung PS, Huntley AC, Gershwin ME. The autoimmune basis of alopecia areata: a comprehensive review. Autoimmun Rev. 2015;14(2):81-9.
- 8. Ito T, Tokura Y. The role of cytokines and chemokines in the T-cell mediated autoimmune process in alopecia areata. Exp Dermatol. 2014;23:787–91.
- 7. Whiting DA. Histopathologic features of alopecia areata: a new look. Arch Dermatol 2003;139(12):1555-9.
- 6. Todes-Taylor N, Turner R, Wood GS, Stratte PT, Morhenn VB. T cell subpopulations in alopecia areata. J Am Acad Dermatol 1984;11(2 Pt 1):216-23.
- 5. Rodriguez TA, Fernandes KE, Dresser KL, Duvic M; National Alopecia Areata Registry. Concordance rate of alopecia areata in identical twins supports both genetic and environmental factors. J Am Acad Dermatol 2010;62(3):525-7.
- 4. de Andrade M, Jackow CM, Dahm N, Hordinsky M, Reveille JD, Duvic M. Alopecia areata in families: association with the HLA locus. J Investig Dermatol Symp Proc 1999;4:220–3.
- 3. De Berker DAR, Messenger AG, Sinclair RD. Disorders of hair. In: Burns T, Breathnach S, Cox N, Griffiths C (Eds). Rook’s Textbook of Dermatology. 7th ed. Oxford: Blackwell Science Ltd; 2004. p.3201–321.
- 2. Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol. 2000;42:549–70.
- 1. Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton 3rd LJ. Incidence of alopecia areata in Olmsted County, Minnesota,1975 through 1989. Mayo Clin Proc 1995;70:628–33.
APA | ATEŞ H (2017). ALOPESİ AREATA’DA TNF-α PROMOTÖR POLİMORFİZMİNİN ANALİZİ. , 7 - 12. |
Chicago | ATEŞ HACI ÖMER ALOPESİ AREATA’DA TNF-α PROMOTÖR POLİMORFİZMİNİN ANALİZİ. (2017): 7 - 12. |
MLA | ATEŞ HACI ÖMER ALOPESİ AREATA’DA TNF-α PROMOTÖR POLİMORFİZMİNİN ANALİZİ. , 2017, ss.7 - 12. |
AMA | ATEŞ H ALOPESİ AREATA’DA TNF-α PROMOTÖR POLİMORFİZMİNİN ANALİZİ. . 2017; 7 - 12. |
Vancouver | ATEŞ H ALOPESİ AREATA’DA TNF-α PROMOTÖR POLİMORFİZMİNİN ANALİZİ. . 2017; 7 - 12. |
IEEE | ATEŞ H "ALOPESİ AREATA’DA TNF-α PROMOTÖR POLİMORFİZMİNİN ANALİZİ." , ss.7 - 12, 2017. |
ISNAD | ATEŞ, HACI ÖMER. "ALOPESİ AREATA’DA TNF-α PROMOTÖR POLİMORFİZMİNİN ANALİZİ". (2017), 7-12. |
APA | ATEŞ H (2017). ALOPESİ AREATA’DA TNF-α PROMOTÖR POLİMORFİZMİNİN ANALİZİ. Afyon Kocatepe Üniversitesi Kocatepe Tıp Dergisi, 18(1), 7 - 12. |
Chicago | ATEŞ HACI ÖMER ALOPESİ AREATA’DA TNF-α PROMOTÖR POLİMORFİZMİNİN ANALİZİ. Afyon Kocatepe Üniversitesi Kocatepe Tıp Dergisi 18, no.1 (2017): 7 - 12. |
MLA | ATEŞ HACI ÖMER ALOPESİ AREATA’DA TNF-α PROMOTÖR POLİMORFİZMİNİN ANALİZİ. Afyon Kocatepe Üniversitesi Kocatepe Tıp Dergisi, vol.18, no.1, 2017, ss.7 - 12. |
AMA | ATEŞ H ALOPESİ AREATA’DA TNF-α PROMOTÖR POLİMORFİZMİNİN ANALİZİ. Afyon Kocatepe Üniversitesi Kocatepe Tıp Dergisi. 2017; 18(1): 7 - 12. |
Vancouver | ATEŞ H ALOPESİ AREATA’DA TNF-α PROMOTÖR POLİMORFİZMİNİN ANALİZİ. Afyon Kocatepe Üniversitesi Kocatepe Tıp Dergisi. 2017; 18(1): 7 - 12. |
IEEE | ATEŞ H "ALOPESİ AREATA’DA TNF-α PROMOTÖR POLİMORFİZMİNİN ANALİZİ." Afyon Kocatepe Üniversitesi Kocatepe Tıp Dergisi, 18, ss.7 - 12, 2017. |
ISNAD | ATEŞ, HACI ÖMER. "ALOPESİ AREATA’DA TNF-α PROMOTÖR POLİMORFİZMİNİN ANALİZİ". Afyon Kocatepe Üniversitesi Kocatepe Tıp Dergisi 18/1 (2017), 7-12. |